| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 08/15/2013 | US20130209366 Glutathione-Lanthionine Compounds and Methods Related Thereto |
| 08/15/2013 | CA2875983A1 Treatment of hypoglycemia |
| 08/15/2013 | CA2805972A1 Improved methods of engraftment |
| 08/14/2013 | EP2626418A1 Method for activating helper t cell |
| 08/14/2013 | EP2626080A2 Conjugated factor VIII molecules |
| 08/14/2013 | EP2626079A2 Conjungated factor VIII molecules |
| 08/14/2013 | EP2626078A1 Inoculation of recombinant viral vectors for rapid pre-exposure prevention and post-exposure protection against alphavirus-induced encephalitides |
| 08/14/2013 | EP2625196A1 Fusion polypeptides comprising tir and dimerization domain for modulation of tlr/innate immunity signaling |
| 08/14/2013 | EP2625195A2 Cancer targets |
| 08/14/2013 | EP2624860A2 Inhibitors of PDE4 binding to HSP20 |
| 08/14/2013 | EP2624859A1 Factor ii and fibrinogen for treatment of haemostatic disorders |
| 08/14/2013 | EP2624858A1 Use of a phosphopeptide able to block her3/p85 interaction for the treatment of her2 hyper-expressing tumours |
| 08/14/2013 | EP2624857A2 Innovative discovery of therapeutic, diagnostic, and antibody compositions related protein fragments of tryptophanyl trna synthetases |
| 08/14/2013 | EP2624856A1 Moesin fragments associated with immune thrombocytopenia |
| 08/14/2013 | EP2624855A1 Moesin fragments associated with aplastic anemia |
| 08/14/2013 | EP2624854A1 Moesin modulators and uses thereof |
| 08/14/2013 | EP2624853A1 Novel use of antimicrobial peptides in regeneration of skin cells |
| 08/14/2013 | EP2624852A1 Diagnostic and therapeutic uses of moesin fragments |
| 08/14/2013 | EP2624851A1 Moesin fragments and uses thereof |
| 08/14/2013 | EP2624850A1 Peptides containing tryptophan |
| 08/14/2013 | EP2624849A2 Multivalent synthetic compounds as antibiotic treatment |
| 08/14/2013 | EP2624848A2 Compositions comprising multivalent synthetic ligands of surface nucleolin and glycosaminoglycans |
| 08/14/2013 | EP2624842A2 Use of hyaluronan for promoting angiogenesis |
| 08/14/2013 | EP2624840A1 New treatments of hepatitis c virus infection |
| 08/14/2013 | EP2624816A2 Stimulation of neuroregeneration by flavonoid glycosides |
| 08/14/2013 | EP2624702A2 Anti-biofilm compositions and methods for using |
| 08/14/2013 | EP2149585B1 Use of antagonistic anti-CD40 monoclonal antibodies |
| 08/14/2013 | CN103249429A Buffered ophthalmic compositions and methods of use thereof |
| 08/14/2013 | CN103249427A Fast-acting insulin in combination with long-acting insulin |
| 08/14/2013 | CN103249426A Methods and compositions comprising cyclic analogues of histatin 5 for treating wounds |
| 08/14/2013 | CN103249425A Methods and compositions for delivering interleukin- receptor antagonist |
| 08/14/2013 | CN103249424A Novel cyclosporin derivatives for the treatment and prevention of a viral infection |
| 08/14/2013 | CN103249423A Methods for the prevention or treatment of no-eflow following ischemia/reperfusion injury |
| 08/14/2013 | CN103243116A Method for preparing intragenus recombinant fungal immunomodulatory proteins and application of intragenus recombinant fungal immunomodulatory proteins |
| 08/14/2013 | CN103242452A Method for amplifying lymphocytes by using interleukin 15 receptor segment-interleukin 2 compound |
| 08/14/2013 | CN103242444A Modulation of SIRP-alpha - CD47 interaction for increasing human hematopoietic stem cell engraftment and compounds therefor |
| 08/14/2013 | CN103242430A Angiotensin-converting enzyme inhibitory peptide, and preparation method and application thereof |
| 08/14/2013 | CN103242429A Simulation oligopeptide of vascular endothelial growth factor (VEGF) epitope and application of simulation oligopeptide |
| 08/14/2013 | CN103242428A Glypican-3 (GPC3)-derived tumor rejection antigenic peptides useful for HLA-A2-positive patients and pharmaceutical comprising the same |
| 08/14/2013 | CN103239736A Method for adjusting glycolysis and gluconeogenesis and applications of method |
| 08/14/2013 | CN103239731A Edible buccal patch for treating dental ulcer |
| 08/14/2013 | CN103239726A Stable and long-acting rhIL2-HSA fusion protein liquid preparation |
| 08/14/2013 | CN103239716A Application of SIRT1 (silent information regulator 1) in preparation of medicines for treating severe burns or wounds |
| 08/14/2013 | CN103239715A Traditional Chinese medicine composition for preventing and treating cardiovascular disease and constipation and application thereof |
| 08/14/2013 | CN103239714A Protein and pharmaceutical composition for treating ischemic diseases |
| 08/14/2013 | CN103239713A Method for building diabetic nephropathy microinflammation mice model |
| 08/14/2013 | CN103239712A HIV (human immunodeficiency virus) microbicide and application thereof |
| 08/14/2013 | CN103239711A Triptorelin injection and preparation method thereof |
| 08/14/2013 | CN103239710A Polypeptide with anti-tumor activity and application thereof |
| 08/14/2013 | CN103239709A Preparation method and use of thymopentin sustained-release preparation |
| 08/14/2013 | CN103239708A Pharmaceutical composition for treating hypertension |
| 08/14/2013 | CN103239707A Eye drop for treating myopia |
| 08/14/2013 | CN103239706A Earthworm protein for reducing blood glucose, improving microcirculation and eliminating diabetic complication and application thereof |
| 08/14/2013 | CN103239705A Composition for crocodile collagen antibacterial peptide and preparation method thereof |
| 08/14/2013 | CN103238849A Production method and application of sericin microcapsules |
| 08/14/2013 | CN103238839A Food composition containing collagen used for maintaining joints |
| 08/14/2013 | CN102920997B Compound tinea ointment |
| 08/14/2013 | CN102698254B Composition for increasing bone mineral density, preparation agent containing same, and preparation method of same |
| 08/14/2013 | CN102652830B Application of Cathelicidin-BF (bungarus fasciatus) in preparation of antineoplastic medicament |
| 08/14/2013 | CN102613453B Marine organism type enteral nutrition preparation for diabetes patients, preparation method of marine organism type enteral nutrition preparation and application |
| 08/14/2013 | CN102477075B Oligopeptide for resisting thrombi and preparation method and application thereof |
| 08/14/2013 | CN102475884B Application of four polypeptides in preparation ACE inhibitor and antihypertensive drug |
| 08/14/2013 | CN102406924B Medicine composition for treating cerebrovascular and cardiovascular diseases as well as preparation method and application thereof |
| 08/14/2013 | CN102397558B Positioning pegylation modified compound of Exendin-4 analog and application thereof |
| 08/14/2013 | CN101955543B Nerve growth factor bound with laminin, and coding gene and application thereof |
| 08/14/2013 | CN101700401B Polyalkylene glycol with moiety for conjugating biologicallyactive compound |
| 08/14/2013 | CN101688210B Erythropoietin fusion protein |
| 08/14/2013 | CN101654475B Antigenic epitope of human tumor necrosis factor alpha and preparation method and application thereof |
| 08/14/2013 | CN101557822B Vaccin against group a beta hemolytic streptococcus and respective process for obtaining thereof |
| 08/14/2013 | CN101541957B Natriuretic polypeptides |
| 08/14/2013 | CN101541825B Process for the purification of Fc-fusion proteins |
| 08/13/2013 | US8507722 Hepatitis C virus inhibitors |
| 08/13/2013 | US8507658 Ex vivo animal or challenge model as method to measure protective immunity directed against parasites and vaccines shown to be protective in the method |
| 08/13/2013 | US8507652 Pharmaceutical composition, dressing and method for treating skin lesion, intermediate composition and process for preparing said dressing, and use of cerium salt associated with a collagen matrix |
| 08/13/2013 | US8507651 Treatment of diseases and conditions mediated by increased phosphorylation |
| 08/13/2013 | US8507648 Detection of truncation mutations by mass spectrometry |
| 08/13/2013 | US8507646 Treating atherosclerosis |
| 08/13/2013 | US8507449 Crystalline D-isoglutamyl-D-tryptophan and the mono ammonium salt of D-isoglutamyl-D-tryptophan |
| 08/13/2013 | US8507448 Human CD154-binding synthetic peptide and uses thereof |
| 08/13/2013 | US8507447 Treatments for gastrointestinal disorders |
| 08/13/2013 | US8507446 Use of PEDF-derived polypeptides for treating liver cirrhosis |
| 08/13/2013 | US8507445 Compositions and methods of use of targeting peptides for diagnosis and therapy of human cancer |
| 08/13/2013 | US8507444 ApoIII and the treatment and diagnosis of diabetes |
| 08/13/2013 | US8507443 Anticancer agent |
| 08/13/2013 | US8507442 Methods of use for an antibody against human frizzled receptors 1, 2. 5, 7 or 8 |
| 08/13/2013 | US8507441 Use of endostatin peptides for the treatment of fibrosis |
| 08/13/2013 | US8507440 Protein kinase C peptides for use in withdrawal |
| 08/13/2013 | US8507439 Neuroprotective and neurorestorative method and compositions |
| 08/13/2013 | US8507438 Compositions and methods for the treatment of neurologic and psychiatric conditions |
| 08/13/2013 | US8507437 Apoptosis-modulating p53 protein therapy for vascular disorders and nanoparticles containing the same |
| 08/13/2013 | US8507436 Peptides derived from plasminogen activator inhibitor-1 and uses thereof |
| 08/13/2013 | US8507435 Juvenile hemochromatosis gene (HFE2A) cleavage products and uses thereof |
| 08/13/2013 | US8507434 Peptide modulators of angiogenesis and use thereof |
| 08/13/2013 | US8507433 Cardioprotective effects of GHRH agonists |
| 08/13/2013 | US8507432 Controlled release formulations of octreotide |
| 08/13/2013 | US8507431 Methods for accelerating wound healing by administration of a preadipocyte modulator or an adipocyte modulator |
| 08/13/2013 | US8507430 Methods for administering FGF18 |
| 08/13/2013 | US8507429 Sugar chain added GLP-1 peptide |
| 08/13/2013 | US8507428 Glucagon analogs exhibiting GIP receptor activity |
| 08/13/2013 | US8507427 Structural and mechanistic basis for novel compound biosynthesis using the 4-electron hexose oxidase |